IDO1 and neoplasm: Overall, these data suggest that under normal (immunocompetent), conditions of tumor growth, there is sufficient immune-dependent IFNγ signaling to drive Ido1 expression, and this can be recapitulated at similar expression levels in vitro by supplementing cultured cells with IFNγ 1 ng/mL (Figures 1E and S1A).